Correction to: Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan
- 128 Downloads
Correction to: Clinical and Experimental Nephrology https://doi.org/10.1007/s10157-018-1632-9
In the original publication of the article, two sentences in the “Results” section were published incorrectly. The corrected texts are provided below:
In the first paragraph of the section “Effectiveness”, 10th line should read as “The administered dose of darbepoetin (mean ± SD, µg) in the effectiveness analysis”.
In the fourth paragraph of the section “Effectiveness”, 1st line should read as “Female patients or those with advanced age…baseline systolic blood pressure ≥ 130 mmHg”.